To evaluate the relative contribution of CD8+ cells and NK cells in the enhanced antitumor immunity in ST2−/− mice in vivo, we depleted either one or the other cell population, following tumor challenge in ST2−/− and WT animals. The gene discussed is IL1RL1; the disease is neoplasm.